Zobrazeno 1 - 10
of 19
pro vyhledávání: '"N. Vidnovic"'
Autor:
Anthony M. Harrison, Norbert Avril, Nicholas A. DeMonaco, N. Vidnovic, Samuel A. Jacobs, Judith M. Joyce, Kenneth A. Foon, Kenneth S. McCarty, Steven H. Swerdlow
Publikováno v:
Molecular imaging and biology. 11(1)
90Yttrium-ibritumomab-tiuxetan (Zevalin) is an effective treatment for relapsed or refractory low-grade, follicular, or transformed B-cell NHL. The purpose of this study is to assess whether tissue and cellular localization of 90Y-ibritumomab–tiuxe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e688bb65b6c591fd6eaab6c2786af338
https://pubmed.ncbi.nlm.nih.gov/18773247
https://pubmed.ncbi.nlm.nih.gov/18773247
Autor:
Dennis C. Sgroi, Chee-Onn Leong, Paul E. Goss, N. Vidnovic, Leif W. Ellisen, Paula D. Ryan, Steven J. Isakoff, Maurice Phillip DeYoung
Publikováno v:
Journal of Clinical Oncology. 25:10522-10522
10522 Background: Triple-negative breast cancer (ER-, PgR- and HER2-negative) has a poor prognosis relative to other subtypes, even with the best available chemotherapy. We recently reported that in squamous cell cancers, p63 promotes survival by dir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29979b571dacc5761bd17e816d7ebce9
https://doi.org/10.1200/jco.2007.25.18_suppl.10522
https://doi.org/10.1200/jco.2007.25.18_suppl.10522
Publikováno v:
European Journal of Cancer Supplements. 4:119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::295417077b76a755b608d114393ee556
https://doi.org/10.1016/s1359-6349(06)70390-1
https://doi.org/10.1016/s1359-6349(06)70390-1
Autor:
B. McCook, Samuel A. Jacobs, N. Vidnovic, Norbert Avril, Judith M. Joyce, M. W. Schuster, F. Torok
Publikováno v:
Journal of Clinical Oncology. 23:6669-6669
6669 Background: Yttrium 90 ibritumomab tiuxetan (90Y IT [Zevalin]) is approved for the treatment of relapsed or refractory B-cell NHL achieving durable responses in heavily pretreated patients. Pr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c9feb57a7b669ca73c3bb1582245d3b
https://doi.org/10.1200/jco.2005.23.16_suppl.6669
https://doi.org/10.1200/jco.2005.23.16_suppl.6669
Autor:
Anthony M. Harrison, Kenneth A. Foon, S. A. Swerdlow, N. Vidnovic, Samuel A. Jacobs, Norbert Avril, Kenneth S. McCarty
Publikováno v:
Journal of Clinical Oncology. 23:2547-2547
2547 Background: Yttrium-90 ibritumomab tiuxetan (90Y IT, Zevalin) is effective treatment for relapsed or refractory low-grade, follicular, or transformed B-cell NHL although affected lymph nodes m...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27ab4235b6f7afa947f42ea9a8d2c985
https://doi.org/10.1200/jco.2005.23.16_suppl.2547
https://doi.org/10.1200/jco.2005.23.16_suppl.2547
Autor:
Kenneth A. Foon, Norbert Avril, Kenneth S. McCarty, Anthony M. Harrison, Steven H. Swerdlow, Samuel A. Jacobs, Wayne Saville, N. Vidnovic
Publikováno v:
Blood. 104:4569-4569
Ytrrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) is indicated for the treatment of relapsed or refractory low-grade, follicular, or transformed B-cell NHL at relapse or upon confirmation of refractory disease. Long-term responses in excess of 6 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d60e12182c62885716003ffa6e93c149
https://doi.org/10.1182/blood.v104.11.4569.4569
https://doi.org/10.1182/blood.v104.11.4569.4569
Autor:
Judy Joyce, N. Vidnovic, Barry McCook, Samuel A. Jacobs, Norbert Avril, Arturo Molina, Frank Torok
Publikováno v:
Blood. 104:5238-5238
Background: As the first radioimmunotherapeutic (RIT) agent approved for the treatment of relapsed or refractory B-cell NHL, yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) has been shown to achieve durable responses in heavily pretreated NHL patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e98b9e0944a944764a9cebdade6f0f2d
https://doi.org/10.1182/blood.v104.11.5238.5238
https://doi.org/10.1182/blood.v104.11.5238.5238
Autor:
S. Jacobs, A. Harrison, S. Swerdlow, K. Foon, N. Avril, N. Vidnovic, J. Joyce, N. DeMonaco, K. McCarty
Publikováno v:
Molecular Imaging & Biology; Jan2009, Vol. 11 Issue 1, p39-45, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.